Literature DB >> 1085300

Age and activity effects on rate of bone mineral loss.

D M Smith, M R Khairi, J Norton, C C Johnston.   

Abstract

It has been postulated that the rate of mineral loss in postmenopausal women remains constant with aging and that the decreased activities of daily living associated with aging contribute to mineral loss. These hypothese were examined by measuring the bone mineral content at the midshaft of the radius with the photon absorption technique. The estimated rate of loss was calculated in a cross-sectional study as the regression coefficient of bone mineral content vs. age and in a longitudinal study as the regression coefficient of bone mineral content vs. time. In the cross-sectional study, Group A, which consisted of 264 women aged 50-72 yr, had an estimated rate of loss of -0.0114 +/- 0.0014 (SE) g/cm per yr. Group B, which consisted of 266 women aged 73-96 yr, had an estimated rate of loss of -0.0055 +/- 0.0017 g/cm per yr. In the longitudinal study, Group C consisted of 33 women aged 51-65 yr who were followed for an average of 4.5 yr with a mean number of 16 visits per subject; they were found to have a mean rate of loss of -0.00990 +/- 0.00107 g/cm per yr. Group D consisted of 38 women aged 70-91 yr who were followed for an average of 3.8 yr with a mean number of 31 visits per subjects; they were found to have a mean rate of loss of -0.00020 +/- 0.00236 g/cm per yr. The estimated and directly measured rates of loss were more rapid in the younger groups than in the older groups (A vs. B, P less than 0.001; C vs. D, P less than 0.001). These data demonstrate that the mean rate of mineral loss is not constant with aging and that in elderly subjects it is significantly slower than that of the earlier postmenopausal years. Since the elderly women were the less active, these findings suggest that factors other than decreased physical activity are more important in determining the rates of mineral loss.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085300      PMCID: PMC333230          DOI: 10.1172/JCI108518

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  A method for evaluating disability in patients with Parkinson's disease.

Authors:  G J CANTER; R DE LA TORRE; M MIER
Journal:  J Nerv Ment Dis       Date:  1961-08       Impact factor: 2.254

2.  Densites of bones of white and Negro skeletons.

Authors:  M TROTTER; G E BROMAN; R R PETERSON
Journal:  J Bone Joint Surg Am       Date:  1960-01       Impact factor: 5.284

3.  The measurement of sequential changes in cortical bone geometry.

Authors:  A Horsman; M Simpson
Journal:  Br J Radiol       Date:  1975-06       Impact factor: 3.039

4.  The measurement of rates of mineral loss with aging.

Authors:  D M Smith; J A Norton; R Khairi; C C Johnston
Journal:  J Lab Clin Med       Date:  1976-05

5.  Testing a linear relation among variances.

Authors:  W G COCHRAN
Journal:  Biometrics       Date:  1951-03       Impact factor: 2.571

6.  Bone mineral content: relationship to muscle strength in normal subjects.

Authors:  M Sinaki; J L Opitz; H W Wahner
Journal:  Arch Phys Med Rehabil       Date:  1974-11       Impact factor: 3.966

7.  Age trends of bone mineral mass, muscle width, and subcutaneous fat in normals and osteoporotics.

Authors:  S Meema; D B Reid; H E Meema
Journal:  Calcif Tissue Res       Date:  1973-05-09

8.  Bone mineral in the radius and vertebral osteoporosis in an insured population. A correlative study using 125-I photon absorption and miniature roentgenography.

Authors:  N F Goldsmith; J O Johnston; G Picetti; C Garcia
Journal:  J Bone Joint Surg Am       Date:  1973-09       Impact factor: 5.284

9.  The loss of bone mineral with aging and its relationship to risk of fracture.

Authors:  D M Smith; M R Khairi; C C Johnston
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

10.  Osteoporosis and the effects of ageing on bone mass in elderly men and women.

Authors:  P Adams; G T Davies; P Sweetnam
Journal:  Q J Med       Date:  1970-10
View more
  19 in total

1.  Predicting the effects of estrogen replacement therapy on lumbar bone mineral density in oophorectomized women: analysis of a 10-year longitudinal study.

Authors:  Hideaki Nagata; Masahiro Nozaki; Hitoo Nakano
Journal:  Osteoporos Int       Date:  2003-10-08       Impact factor: 4.507

2.  Longitudinal changes in bone mass after one year as measured by different techniques in patients with osteoporosis.

Authors:  S M Ott; R F Kilcoyne; C H Chesnut
Journal:  Calcif Tissue Int       Date:  1986-09       Impact factor: 4.333

Review 3.  Impact of bone mineral measurements on osteoporosis.

Authors:  I Fogelman; A Rodin; G Blake
Journal:  Eur J Nucl Med       Date:  1990

4.  Variability of vertebral and femoral postmenopausal bone loss: a longitudinal study.

Authors:  J M Pouillès; F Trémollières; C Ribot
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

Review 5.  [The pre-climacteric patient].

Authors:  H P Zahradnik
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

6.  Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density.

Authors:  N A Pocock; J A Eisman; M G Yeates; P N Sambrook; S Eberl
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

7.  The pathophysiology of bone and joint disease.

Authors:  S L Teitelbaum; P G Bullough
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

Review 8.  Age changes in human bone: an overview.

Authors:  W D Sharpe
Journal:  Bull N Y Acad Med       Date:  1979-09

Review 9.  Premenopausal bone loss: fact or artifact?

Authors:  B J Riis
Journal:  Osteoporos Int       Date:  1994       Impact factor: 4.507

10.  A cross-sectional study of age-related loss of mineral content of phalangeal bone in men and women.

Authors:  W T Trouerbach; J C Birkenhäger; P I Schmitz; A M van Hemert; J L van Saase; H J Collette; A W Zwamborn
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.